Financial Summary (All financials)
In millions, except per share items | Dec-31-22 | Mar-31-21 | Mar-31-20 | Mar-31-19 | Mar-31-18 |
Revenues | 427.2 | 19.5 | 0.1 | 0.5 | 0.0 |
Revenue growth | | 19352.2% | -80.2% | | |
Cost of goods sold | 15.1 | 0.0 | 0.6 | 0.6 | 0.0 |
Gross profit | 412.1 | 19.5 | -0.5 | -0.1 | 0.0 |
Gross margin | 96.5% | 100.0% | -520.0% | -21.6% | |
Selling, general and administrative | 397.0 | 15.8 | 5.5 | 1.8 | 0.9 |
Research and development | 4.1 | 3.5 | 1.8 | 0.7 | 0.2 |
General and administrative | 375.0 | | | | |
EBITA | -14.9 | -19.3 | -7.8 | -2.6 | -1.2 |
EBITA margin | -3.5% | -99.2% | -7797.5% | -509.5% | |
Amortization of intangibles | 0.2 | 0.1 | 0.0 | 0.0 | |
EBIT | -15.1 | -19.4 | -7.8 | -2.6 | -1.2 |
EBIT margin | -3.5% | -99.5% | -7837.9% | -517.5% | |
Pre-tax income | -14.3 | -40.8 | -9.6 | -4.3 | -1.2 |
Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Net income | -14.4 | -40.8 | -9.6 | -4.3 | 0.0 |
Net margin | -3.4% | -209.5% | -9603.9% | -851.0% | |
|
Diluted EPS | ($0.82) | ($4.25) | ($1.77) | ($0.40) | $0.00 |
Shares outstanding (diluted) | 17.4 | 9.6 | 5.4 | 10.7 | 8.9 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|